Insights

Gathering insights about Dario…

Similar companies to Dario

Dario Tech Stack

Dario uses 8 technology products and services including Fivetran, GitHub Actions, Keras, and more. Explore Dario's tech stack below.

Fivetran
Data Management
GitHub Actions
Devops
Keras
Machine Learning
Wow
Marketing Analytics
Office 365
Office Suites
C++
Programming Languages
BrowserStack
Testing And Qa
X-Content-Type-Options
Web & Portal Technology

Media & News

Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms
Growing body of peer-reviewed publications and rigorously reviewed conference research reinforces Dario's position as trusted partner for organizations seeking to reduce cost, improve outcomes and simplify digital health delivery NEW YORK, Jan. 21, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced that it has surpassed 100 scientific studies, including peer-reviewed journal publications and peer-reviewed conference abstracts, marking a significant milestone in the Company's commitment to delivering rigorously validated outcomes for employers, health plans and their members. Reaching this threshold places Dario among the top tier of digital health vendors by volume and depth of scientifically reviewed evidence, an important differentiator as self-insured employers, consultants and health plans increasingly demand rigorous proof of measurable impact – not merely engagement metrics or modeled results.
Jan 21, 2026 | www.prnewswire.com
Contrasting DarioHealth (NASDAQ:DRIO) and CardioGenics (OTCMKTS:CGNH)
CardioGenics (OTCMKTS:CGNH - Get Free Report) and DarioHealth (NASDAQ: DRIO - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, risk, profitability and valuation. Institutional and Insider Ownership 33.4% of DarioHealth shares are owned
Dec 27, 2025 | www.defenseworld.net
Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members
First in-market activation of Dario's GenAI roadmap lays clinical and technical foundation for a seamless, conversational AI experience across the entire Dario platform DarioIQ™ reflects years of innovation in data science, engineering and clinical design backed by Dario's proprietary AI models and 13 billion real-world data points, further reinforcing Dario's position as a leader in digital health NEW YORK , Dec. 10, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced the launch of the Dario Health app enhanced with DarioIQ™, the Company's new artificial intelligence ("AI") layer, delivered as a direct-to-consumer first version for an initial cohort of hypertension members who enrolled to access the new experience. This launch marks the first major milestone in Dario's multi-phase introduction of conversational AI designed to enhance, not replace, the human-centered guidance central to chronic condition management.
Dec 10, 2025 | www.prnewswire.com
Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio
Peer-reviewed JMIR Cardio study demonstrates real-world clinical impact of data-driven digital nudges on hypertension outcomes Data-driven engagement translates to lower health risks and downstream cost savings for Dario clients Results highlight Dario's ability to deliver lasting impact and further cement the Company's position as a proven leader in evidence-based digital care NEW YORK , Dec. 4, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced publication of a new peer-reviewed study in JMIR Cardio demonstrating that data-driven nudges delivered via Dario's digital health platform are associated with significant and sustainable improvements in blood pressure ("BP") outcomes. The study, titled " The Impact of Digital Intervention Messages Targeting Users With High Blood Pressure Events: Retrospective Real-World Study ," analyzed real-world BP data from platform users whose health was tracked over time, comparing a cohort that received digital intervention messages to a propensity-matched control group.
Dec 04, 2025 | www.prnewswire.com
DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date
34 new employer clients added in the past two weeks expected to contribute to H1 2026 revenue Data-driven outcomes drive employer adoption, highlighting Dario's market leadership as partner of choice, underscoring employer confidence, repeatability and scalability NEW YORK , Dec. 2, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced that it has secured 34 new employer clients in the past two weeks, reaching a total of 79 clients signed year-to-date, exceeding its 2025 target of 40 new clients by 98%. These new agreements, which collectively represent tens of thousands of covered lives, further validate Dario's strong penetration, stickiness and repeatability in the mid-size employer market.
Dec 02, 2025 | www.prnewswire.com
DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year
Sanofi and Symphony Health teams conducted the study demonstrating how Dario's digital, diabetes intervention platform reduces real-world healthcare burden and cost compared to usual care Representing a high-rigor, real world analysis, the study found Dario users, as compared to matched individuals receiving usual care, had 23% lower hospitalization rates and 26% lower all-cause charges More frequent engagement on the Dario platform associated with fewer inpatient and ER events NEW YORK , Nov. 24, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced the publication of a new peer-reviewed study in the Journal of Medical Internet Research (JMIR), a highly influential digital health journal, evaluating healthcare utilization and medical costs among Dario users compared to matched non-users receiving usual care. The study, "Effects of a Digital Health Intervention for Adults with Type 2 Diabetes Mellitus on Health Care Resource Use and Health Care Charges in the United States: Retrospective Cohort Study," was not authored by Dario, but rather conducted by researchers at Sanofi and Symphony Health.
Nov 24, 2025 | www.prnewswire.com
DarioHealth Corp. (DRIO) Q3 2025 Earnings Call Transcript
DarioHealth Corp. ( DRIO ) Q3 2025 Earnings Call November 13, 2025 8:30 AM EST Company Participants Zoe Harrison Erez Raphael - CEO & Director Steven Nelson - President & Chief Commercial Officer Chen Franco-Yehuda - CFO, Treasurer & Secretary Conference Call Participants Lucas Romanski - TD Cowen, Research Division Theodore O'Neill - Litchfield Hills Research, LLC Presentation Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Third Quarter 2025 Results Conference Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025.
Nov 13, 2025 | seekingalpha.com

Dario's Email Address Formats

Dario uses at least 1 format(s):

Dario Email Formats	Example	Percentage
First.Last@dariohealth.com	John.Doe@dariohealth.com	48%
FirstL@dariohealth.com	JohnD@dariohealth.com	31%
First@dariohealth.com	John@dariohealth.com	17%
First.L@dariohealth.com	John.D@dariohealth.com	4%

Frequently Asked Questions

Where is Dario's headquarters located?

Dario's main headquarters is located at 18 West 18th Street New York, New York 10011 United States. The company has employees across 5 continents, including AsiaNorth AmericaEurope.

What is Dario's stock symbol?

Dario is a publicly traded company; the company's stock symbol is DRIO.

What is Dario's official website and social media links?

Dario's official website is dariohealth.com and has social profiles on LinkedIn Crunchbase.

What is Dario's NAICS code?

Dario's NAICS code is 71394 - Fitness and Recreational Sports Centers.

How many employees does Dario have currently?

As of February 2026, Dario has approximately 238 employees across 5 continents, including AsiaNorth AmericaEurope. Key team members include Ceo: E. R.Chief Medical Officer: O. M.Chief Operating Officer: L. D.. Explore Dario's employee directory with LeadIQ.

What industry does Dario belong to?

Dario operates in the Wellness and Fitness Services industry.

What technology does Dario use?

Dario's tech stack includes FivetranGitHub ActionsKerasWowOffice 365C++BrowserStackX-Content-Type-Options.

What is Dario's email format?

Dario's email format typically follows the pattern of First.Last@dariohealth.com. Find more Dario email formats with LeadIQ.

When was Dario founded?

Dario was founded in 2011.

Dario

Q: What is Dario's official website and social media links?

Dario's official website is dariohealth.com. Dario has social profiles on LinkedIn.

Q: How many employees does Dario have currently?

Dario has approximately 238 employees.

Q: What technology does Dario use?

Dario's tech stack includes Node.js, Django, Bing Ads, WooCommerce, Wow.

Wellness and Fitness ServicesNew York, United States201-500 Employees

DarioHealth Corp. (NASDAQ:DRIO) Dario is changing the way people manage their health, with consumer-friendly digital solutions proven to power lasting behavior change. Dario integrates comprehensive support across a wide range of common and connected health needs, from well-being to chronic condition management, to help our members find long-term success. Billions of data insights from a decade of direct-to-consumer experience fuel Dario’s highly personalized and dynamic member experiences that are constantly adapting to meet changing member needs. This unique approach is proven to keep people engaged in healthier behaviors over time, resulting in high-impact clinical and financial outcomes for our clients.

Our mission at Dario is to power the behavior change that drives better health. 

Investors, please visit:
https://dariohealth.investorroom.com/Welcome